We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Pushes Three-Pronged Approach to Postmarket Risk Minimization
EU Pushes Three-Pronged Approach to Postmarket Risk Minimization
Generic drugmakers in the EU must create a program to assess the effectiveness of their risk minimization efforts for each marketed drug, EU regulators say.